1. **Galderma’s Focus:** The summary highlights Galderma’s commitment to dermatology, particularly its dedication to research and development within the field. 2.
EADV is a platform for collaboration, innovation, and knowledge sharing. It is a global event that brings together dermatologists, researchers, and industry professionals from all over the world. It is a unique opportunity to learn from the best and to network with like-minded individuals. EADV provides a platform for scientific advancements, research, and clinical practice.
**Itch: A Multifaceted Challenge for Patients and Healthcare Professionals**
The symposium will feature renowned experts in dermatology, allergology, and psychology, who will share their insights on the impact of itch on patients’ lives. These experts will discuss the latest research findings, treatment options, and emerging technologies that can help manage both diseases. The event will also provide a platform for open discussion and collaboration among healthcare professionals, allowing them to share their experiences and best practices. The symposium will cover a range of topics, including:
The event will also feature a panel discussion with leading dermatologists, discussing the future of sensitive skin care. The panel will address key challenges and opportunities in the development of new and effective treatments for sensitive skin. The discussion will be moderated by Dr. David E. Fisher, a renowned expert in dermatology.
* The session will focus on a new skin quality assessment scale developed by Galderma. * This scale goes beyond simply assessing skin diseases and aims to evaluate skin quality as a whole. * The scale will be used to identify and address skin quality issues that contribute to a patient’s overall well-being.
More details on Galderma’s scientific presentations at EADV can be found here About Galderma Galderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ-the skin-meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information:
References: Pereira MP, et al. Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need. J Eur Acad Dermatol Venereol. 2018;32(12):2224-2229. doi:10.1111/jdv.15107 Silverberg JI, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340-347. 1016/j.2018.07.006 View source version on businesswire: Permalink
